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ABSTRACT 
 
Background: Lumbar developmental spinal stenosis (DSS) is likely due to genetic influences 
during both fetal and postnatal development of the lumbar vertebrae. DSS patients with pre-
existing narrowing of the spinal canal are at-risk of multi-level compression and recurrence after 
surgery. Various genetic polymorphisms have been suggested to be associated with the disease 
entity of DSS but the genetic basis of a narrowed bony spinal canal of a developmental origin 
have yet to be discussed. Therefore, the aim of this study was to identify possible single 
nucleotide polymorphisms (SNPs) via a genome-wide association study (GWAS) approach and a 
candidate gene platform that were associated with developmental narrowing of the lumbar spinal 
canal. 
Methods: Southern Chinese population-based study volunteers were assessed (age range: 18-55 
years). DSS was defined as the anteroposterior bony spinal canal diameter on T1-weighted axial 
MRI of L1 to S1. Genotyping was performed using the Illumina HumanOmniZhongHua-8 
BeadChip. Using the canal diameter as the quantitative trait, genomic statistical analyses was 
performed.  
Results: A total of 469 subjects were recruited. The mean axial AP measurements noted were: 
L1:21.8mm, L2:21.9mm, L3:22.4mm, L4:20.2mm, L5:19.6mm, and S1:17.3mm. Q-Q plots of 
genome-wide associations found significant differences in L4 and L5 measurements. More 
significant SNPs were found on chromosomes 8, 11, and 18. Low-density lipoprotein receptor-
related protein 5 on chromosome 11 was found to be an important functional gene in canal bony 
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development via candidate gene approach. We found 2 clusters in the findings with one 
including the upper levels (L1-L4) and the other the lower levels (L5 and S1). 
Conclusion: This is the first GWAS addressing DSS. The presence of multiple SNPs suggests a 
multi-factorial origin of DSS. Further analyses noted region-specific genetic predisposition, 
delineating distinct upper to lower lumbar regions of DSS. With better understanding of the DSS 
phenotype and genetic markers, the at-risk population can be identified early, preventative 
measures can be initiated, lifestyle/activity modification can be implemented, and more novel 
and precision-based therapeutics can be developed.  
 
Level of Evidence: Level I Study 
 
 
 
1 
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INTRODUCTION 2 
Lumbar spinal stenosis is one of the most common spine conditions worldwide that often 3 
requires surgery.1 Patients generally have good clinical response after decompression surgery.2-4 4 
However, reoperation is not an uncommon event. In the Spine Patient Outcomes Research Trial 5 
(SPORT) for spinal stenosis, 8% of patients who underwent an operation required another 6 
operation within two years of the index operation and 13% had another operation within four 7 
years.3,4 In a similar study, 23% of patients were reported to require a repeat surgery by ten 8 
years.5 In Korea, Kim et al showed that reoperation rates were up to 74% at 1 year, 9% at 2 years 9 
and 13.4% at 5 years after surgery.6,7 This raises an important concern in clinical practice as 10 
reoperation occurs in both fusion and decompression only surgeries.8 Developmental spinal 11 
stenosis (DSS) is a possible risk factor for reoperation as patients are prone to developing 12 
symptoms at multiple levels due to the presence of pre-existing narrowed canals.  13 
Characteristically, patients with DSS have generalized short pedicles suggestive of 14 
genetic disturbances during the fetal and postnatal period.9 A narrowed spinal canal can be due to 15 
developmental problems, such as the articular processes in an early embryonic stage, 16 
disproportional growth of the lamina and pedicles, and also of the spinal canal and spinal roots.9 17 
Pathological changes in DSS include narrowing of the dorsal aspect of the spinal canal due to 18 
bulging of the inferior articular facets. A paradoxical relationship with the degree of ligamentum 19 
flavum fibrosis has also been observed.10 The lamina is also enlarged with narrowed interlaminar 20 
spaces and the pedicles are also shortened leading to decreased interpedicular distances.11 21 
Vertebral bodies may also be wedged and present with posterior lipping, contributing to the 22 
narrow spinal canal.12 Occasionally, the lower lumbar vertebral levels may produce a trefoil or 23 
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three-leaf clover shaped canal.13 This configuration may also predispose compression of lumbar 24 
and sacral nerve roots.13 Thus, with this distorted canal morphology, patients may develop 25 
claudication symptoms more readily than patients with normally developed canals. 26 
The DSS phenomenon has not been well-defined in the past and its prevalence among the 27 
general population or impact on lumbar spine disease is unknown. Previous studies are limited 28 
by largely generalized measurements of the entire lumbar spine, utilization of variable imaging 29 
modalities, lacking control groups, and were based on heterogeneous populations.14-21 Recent 30 
work suggests that the anteroposterior (AP) bony spinal canal diameter is the most relevant 31 
measurement associated with DSS and can be assessed on both T1- and T2-weight scans.22,23 32 
DSS has been defined as level-specific values of developmental narrowing for levels L1-S1 and 33 
critical values have been determined as <14 mm at L4, <14 mm at L5 and <12 mm at S1.22  34 
Despite the previous work relating to phenotyping, there is a lack of substantial evidence 35 
relating to its genetic predisposition. Even for degenerative lumbar spinal stenosis, gene 36 
association studies have been focused on its symptoms rather than the actual imaging 37 
measurements and are sporadic24,25 and other studies have often confounded the genetic 38 
association with other degenerative findings (e.g. disc degeneration).26 Furthermore, previous 39 
genetic studies were limited to implementing a candidate gene approach rather than the more 40 
accepted and robust measure of genome-wide association studies (GWAS),24-26 whereby 41 
hundreds of thousands of single nucleotide polymorphisms (SNPs) can be screened. With better 42 
understanding of this phenotype-genotype relationship, there is potential to use genetic profiling 43 
to identify the at-risk population. In doing so, preventive measures such as lifestyle and activity 44 
modification, and better monitoring for stenosis development may be implemented. Thus, the 45 
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aim of our study was to identify genetic associations of SNPs with narrowed lumbar spinal 46 
canals via a GWAS approach. The information gathered was used to find where allele frequency 47 
differences between spinal canal diameters are greatest and to investigate for any patterns of 48 
clustering between spinal canal AP diameter and genotypes. 49 
 50 
MATERIALS AND METHODS 51 
Subjects 52 
Based on the Hong Kong Disc Degeneration Population-Based Cohort subjects 53 
(approximately 3,000 probands, ranging from 10 to 88 years of age), a total of 469 adult 54 
individuals who were not symptomatic for stenosis-related symptoms were randomly selected for 55 
analyses. This cohort is a population-based study that openly recruited individuals of Southern 56 
Chinese origin, irrespective of their pain status.27-34 The details of the protocol of this cohort 57 
have been reported elsewhere over the past decade. These 469 subjects (age range: 18-55 years) 58 
were sex- and age-matched. All 469 individuals underwent magnetic resonance imaging (MRI) 59 
examination of the lumbar spine (see MRI assessment section) and blood sampling for DNA 60 
extraction.  This study was approved by the local ethical committee and informed consent was 61 
obtained by all subjects.  62 
 63 
 64 
 65 
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MRI Assessment 66 
For the current study assessing the spinal canal, all subjects underwent axial T1-weighted 67 
3T MRI (Siemens, Berlin and Munich, Germany; Phillips, Amsterdam, Netherlands) of L1-S1. 68 
The axial cut used for measurements included visualization of the bony canal and the thickest 69 
pedicle width. All the clinical and additional imaging details were blinded to the imaging 70 
assessor before and during the measurements. Intra-observer reliability analysis of the canal was 71 
performed on ten subjects. The first and second round of measurements was not performed on 72 
the same day. The program used for measurements was the Centricity Enterprise Web V3.0 (GE 73 
Medical Systems, 2006).  74 
The imaging protocol used included a field of view of 18x18 cm for axial scans. Slice 75 
thickness was 4 mm and slice spacing was 0 mm for axial scans, and the imaging matrix was 76 
288x192.The TR was 700-800 ms and the TE was 8-10 ms. There were 11 slices per vertebral 77 
level and parallel slices were made according to the pedicle levels. The quantitative measurement 78 
used was the AP bony spinal canal diameter in which we have previously determined it to be the 79 
key parameter for diagnosis of DSS.22 On the axial cut, we measured this phenotype from the 80 
posterior midline of the vertebral body to the corresponding midline at the lamina (Figure 1).22 81 
 82 
Genetic Testing and Data Cleaning 83 
Genomic DNA for sequencing was isolated from peripheral blood from all 469 individuals. 84 
A similar protocol for isolation has been performed in previous studies.27,35,36 To extract DNA 85 
from blood, we used a blood extraction kit from Qiagen (consumables company). This kit 86 
  
8 
 
extracted DNA from white blood cells in the blood samples. First, 10ml venous blood would be 87 
collected by ethylene-diamine-tetra-acetic acid (EDTA) tubes to prevent coagulation. The 88 
samples were then stored in -20 degrees Celsius, before running into the DNA extraction kit. 89 
DNA was extracted using a QIAamp DNA mini-kit (Qiagen, Hilden, Germany). This kit could 90 
break blood cells to release their contents, and capture DNA using the provided filter with 91 
charge. After washing the enzyme digested samples with buffers and water, blood DNA could 92 
then be obtained. Genotyping was carried out using the Illumina HumanOmniZhongHua-8 93 
BeadChip as the genotyping platform. This product could genotype 900,015 SNP markers and 94 
was tailored made for studies involving Chinese individuals. This gene chip had coverage of 95 
77% for the SNPs with minor allele frequency (MAF) >5%, and coverage of 73% for the SNPs 96 
with MAF >2.5%.  97 
Quality control was performed with PLINK v1.07.37 For SNPs exclusion quality control, 98 
SNPs with call rates of <95% were removed as very low call rate might be caused by the low-99 
quality markers; SNPs that showed deviation from the Hardy-Weinberg equilibrium (p ≤ 1 × 100 
10−6), non-autosomal SNPs, monomorphic SNPs, SNPs that were not shared among cases and 101 
controls, and SNPs with MAF <5% were removed. The genomic inflation factor λ was calculated 102 
to quantify the extent of the bulk inflation and the excess false positive rate. Twenty samples 103 
were chosen randomly as duplicates and were genotyped. SNPs with Kappa value less than 0.95 104 
were excluded. 105 
 106 
 107 
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Statistical Analyses 108 
Descriptive and frequency statistics were performed of the measurement data.  All values 109 
were expressed as mean with ± standard deviation (SD). Reliability assessment was based on 110 
Cronbach's alpha analysis. Alpha values of reliability were regarded as follows: excellent 111 
(a>0.90), good, (a>0.80), fair (a>70) and poor (a<0.60).38,39 All MRI measurements were 112 
expressed in millimeters (mm). Statistical analyses were performed in PLINK using a linear 113 
model. Linear regression was used for continues trait and logistic regression was used for binary 114 
trait. Age, body weight (kg), body height (m), body mass index (BMI; kg/m2), and sex-type were 115 
used as covariates to adjust for the influences of these factors. The significance level was 116 
adjusted by Bonferroni correction for multiple testing (0.05/SNPs number). Assuming 800,000 117 
SNPs were included after quality control and analysis, the GWAS significance level of the p-118 
value was set at < 6.2 x 10-8. Linear regression analysis and ANOVA testing were utilized if the 119 
slope was significantly greater/smaller than 0. 120 
Quantile-quantile (QQ) plots and Manhattan plots were generated to visualize the 121 
association results. Quantile-quantile (Q-Q) plots were used to investigate if p-values were more 122 
significant (smaller) than that expected by chance. The –log10(P) was plotted for emphasis for 123 
smaller p-values and converted to a positive value. Significant SNPs were indicated by upward 124 
deviation from the diagonal line on the Q-Q plot. 125 
Manhattan plots were used to determine position of significant SNPs in relation to their 126 
chromosome. The Manhattan plot was conducted by plotting –log10(P) against chromosomes. 127 
The -log was used to emphasize the SNP with the smallest p-value (-log8 was genome wide 128 
significant). Candidate gene analysis of previously utilized and identified SNPs in relevant 129 
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lumbar degeneration genes was performed. A list of these candidate genes are listed in table 1. 130 
Clustering of the SNPs in this study was performed using the correlation study via the R 131 
statistical package. This was performed according to each vertebral level to look for patterns of 132 
involvement and region specific variation between lumbar levels.  133 
 134 
RESULTS 135 
The mean age for subjects was 52.8 (SD:9.9) years old and there were 195 (41.6%) males 136 
and 274 (58.4%) females. Excellent intra-observer reliability (a=0.94-0.99) was noted. The mean 137 
body weight was 61.8 kg (SD:11.2), mean body height was 1.63 m (SD:0.1) and the mean BMI 138 
was 23.2 kg/m2 (SD:3.3). The bony spinal canal measurement findings are illustrated in Table 139 
12: 140 
According to Q-Q plot analyses and inspecting significant differences between the 141 
observed and expected p-values, (Figure 2) we found that L1, L2 and L3 were not significant 142 
while S1 was marginally significant. L4 and L5 were more significant and L4 was the most 143 
significant. Based on the Manhattan plot analyses, we found the most significant SNP in L4 144 
(Figure 3A) to be 4kb from the ZNF704 gene (4.33 x 10-7) on chromosome 8. For L5 (Figure 145 
3B), the most significant SNP was found at the DCC gene (p= 4.67 x 10-7) on chromosome 18.  146 
Implementing a candidate gene approach, the most significant SNP was rs3781579 (p = 147 
8.21 x 10-4; Bonferroni threshold: 1.62 x 10-4) of the low-density lipoprotein receptor-related 148 
protein 5 (LRP5) gene indicating that it was a significant candidate gene responsible for DSS 149 
(Figure 4). Other more promising candidate gene results were rs5277 (Prostaglandin-150 
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endoperoxide synthase 2, COX2 at p= 2.63 x 10-3 and rs731236 (VDR Taq I) at p= 6.30 x 10-3, 151 
but did not reach Bonferroni threshold for significance. Based on clustering analysis using the 152 
SNPs discovered in the GWAS analyses, we found that the upper levels of L1 to L4 and the 153 
lower levels of L5 and S1 were clustered separately, indicating that there could be a different 154 
pattern of region-specific genetic predisposition for upper level and lower level involvement for 155 
DSS (Figure 5). 156 
 157 
DISCUSSION 158 
In pre-existing narrowed bony spinal canals, even mild changes associated with 159 
degeneration or aging, such as intervertebral disc bulging and facet hypertrophy, may readily 160 
cause compressive symptoms. The neural structures in an already compromised spinal canal are 161 
especially at-risk. By accurately delineating the heterogeneous complex traits involved in DSS, 162 
we can detect true genetic associations regarding this condition. This is the first study to attempt 163 
to link DSS with genetic markers based on a GWAS approach. Our findings suggest that DSS 164 
has a multi-factorial genetic origin with the presence of multiple SNPs. In addition, DSS behaves 165 
in two clusters, demonstrating “region-specific” genetic predisposition between the upper (i.e. L1 166 
to L4) to the of the lower lumbar spine (L5 and S1).  167 
Predisposing factors of symptomatic DSS includes degeneration of intervertebral discs, 168 
facet joints or the ligamentum flavum.1,10,19,22,40 Some genetic factors have been implicated in the 169 
etiology of lumbar spinal degeneration.41,42 35,36,43 There is likely a direct correlation between 170 
spinal stenosis and disc degeneration because these two pathologies usually coexist. However, 171 
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similar to the situation in spinal stenosis, many studies that discuss lumbar disc degeneration are 172 
not consistent in their definitions.44 35,36,434345464748-5051   173 
To confirm our hypothesis, genomic DNA from peripheral blood of the subjects were 174 
sequenced and the AP diameter of the spinal canal AP was measured as the quantitative trait in 175 
the analysis. From our Q-Q and Manhattan plots, several suggestive signals were found in the 176 
genetic association analysis. We found the most significant single SNP in L4 to be 4kb from the 177 
ZNF704 gene on chromosome 8. Previously, this SNP has been found to be marginally 178 
associated with amyotrophic lateral sclerosis.52 For L5, the most significant SNP was found at 179 
the DCC gene on chromosome 18. This gene codes for a protein that functions as a tumor 180 
suppressor and is frequently mutated or down-regulated in colorectal and esophageal carcinoma. 181 
Although both SNPs have limited relevance regarding bone development, our candidate gene 182 
approach yielded an interesting finding. Using candidate gene data, significant SNPs were 183 
rs3781579 (Lipoprotein receptor related protein 5; LRP5 on chromosome 11), rs5277 184 
(Prostaglandin-endoperoxide synthase 2; COX2) and rs731236 (VDR Taq I). In particular, LRP5 185 
reached Bonferroni significance and is a key component of the Wnt signalling pathway 186 
important for bone development. As such, our preliminary analyses have suggested -- for the first 187 
time in the literature -- that specific genetic markers may be associated with the development of 188 
the stenosis phenotype.  189 
Our study represents the first GWAS. The study was performed on a homogenous 190 
Southern Chinese population based on a reliable MRI phenotype. Although the GWAS did not 191 
identify any genetic associations that reached genome-wide significance (p< 5.0 x 10-8), we did 192 
identify several important candidate genes that are potential candidates for further study. In 193 
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addition, results suggested that the more significant SNPs were found at the L4 and L5 levels, 194 
and clustering showed that the upper and lower vertebral levels had different associations. These 195 
findings further stress the point that DSS has a multifactorial genetic origin, with variable region-196 
specific genetic predispositions that are not uniformed throughout the lumbar spine.  This non-197 
uniformity of region-specific risk factors related to disc degeneration and other MRI phenotypes 198 
(e.g. endplate abnormalities, Modic changes, etc) have also been reported elsewhere.27,34 199 
Although our study represents a homogenous population, further replication studies are needed 200 
to validate our findings in other ethnic groups to assess global generalizability. However, due to 201 
the homogeneity of our sample, this further limits the potential confounds often associated with 202 
heterogenous populations.   203 
Hypothetically, if the patients with DSS can be identified at the index operation, 204 
reoperation at adjacent levels can be avoided with prophylactic canal widening surgery. This 205 
may lead to an overall better function for the patients since they can avoid repeated operations. 206 
However, this is not advocated, is yet premature and the practicality of this approach needs 207 
further investigation. Alternatively, in the advent of the omics era whereby blood biomarkers and 208 
profiling for more precision or personalized approaches to spine care are being sought, having a 209 
refined and better understanding of genetic factors related to various spinal disorders/conditions, 210 
such as DSS, may prove essential. This would allow early profiling of individuals that may be at 211 
risk, which may necessitate further or follow-up imaging analyses, clinical consult and/or 212 
perhaps lifestyle modification. Future investigations into biological pathways and novel 213 
therapeutics early-on in an individual’s lifespan may be further explored. Ultimately, early 214 
identification of DSS may lead to improved patient management, enhanced outcomes and 215 
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decreased health-care costs with less reoperations. Future work should aim to assess these 216 
findings for replication purposes in other ethnic populations.  217 
218 
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FIGURE LEGENDS 367 
Figure 1: Axial MRI scan noting the measurement of the bony spinal canal anteroposterior 368 
diameter (red line). 369 
Figure 2: Q-Q plots of L1 to S1. Note that Q-Q plot compares the observed to that of the 370 
expected p-values. Deviation from the diagonal line equates to a suspected significant result with 371 
respect to the expressed phenotype in relation to genetic markers. 372 
Figure 3: Manhattan plots for the (A) L4 and (B) L5 anteroposterior bony spinal canal. 373 
Figure 4: Candidate gene analysis illustrates that chromosome 11 reaches Bonferroni threshold 374 
of 10-4, indicating that LRP5 was a significant candidate gene responsible for developmental 375 
spinal stenosis.  376 
Figure 5: Correlation of levels demonstrates genetic clustering of the upper (L1 to L4) to that of 377 
the lower spinal levels (L5 and S1). 378 
 379 
 380 
 381 
  382 
